Talk Evidence - digital clubbing, osteoarthritis & sustainable EBM
We ’re back for the December Talk Evidence, and this month we’re being very digital
Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand
Then (13.30) Carl gets us all to check our fingers for club bing, and we find out how useful it is as a test for lung cancer
(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.
(33.50) We talk AF and the Apple Watch - and why drop out is going to b e a massive problem for t...
Source: The BMJ Podcast - December 16, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - digital clubbing, osteoarthritis & sustainable EBM
We’re back for the December Talk Evidence, and this month we’re being very digital
Firstly,(1.20) Helen tells us about arthritic fingers - should we be using prednisolone for treatment when people have painful osteoarthritis of the hand
Then (13.30) Carl gets us all to check our fingers for clubbing, and we find out how useful it is as a test for lung cancer
(23.10) Minna Johansson GP and Cochrane Sweden researcher explains why EBM needs to take into account sustainability, and why that isn’t just carbon footprint.
(33.50) We talk AF and the Apple Watch - and why drop out is going to be a massive problem for the ...
Source: The BMJ Podcast - December 16, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Discussing Subset Of 11 Mesothelioma Patients
Christopher Haqq M.D., PhD Executive Vise President Of Atara Biotherapeutics Discusses Subset Of 11 Mesothelioma Patients.
Author: Cancer-News
Added: 04/25/2019 (Source: Oncology Tube)
Source: Oncology Tube - April 25, 2019 Category: Cancer & Oncology Source Type: podcasts
The need for RCTs in immunotherapy for mesothelioma
Speaking from the 2018 European Lung Cancer Congress (ELCC) in Geneva, Switzerland, Dean Fennell, PhD, FRCP, of the University of Leicester, Leicester, UK, stresses the need for increased randomized c...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Therapeutic targets for mesothelioma and sarcomatoid carcinoma
In this video, Dean Fennell, PhD, FRCP, of the University of Leicester, Leicester, UK, discusses upcoming therapeutic targets for mesothelioma and sarcomatoid carcinoma. Speaking at the 2018 European ...
Author: VJOncology
Added: 08/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Lung Cancer Risk Factors [720p]
Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, discusses smoking, asbestos, radon and other risk factors for lung cancer.
Author: cancergrace
Added: 07/30/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 30, 2018 Category: Cancer & Oncology Source Type: podcasts
My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & amp; Mesothelioma (BMIC-037)
Dr. Jack West reviews his top 5 abstracts in stage I-III non-small cell lung cancer, small cell lung cancer, and mesothelioma at ASCO 2018, explaining why each is poised to change the landscape of pat...
Author: BeaconMedIC
Added: 05/23/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 23, 2018 Category: Cancer & Oncology Source Type: podcasts
Emerging Options for Malignant Pleural Mesothelioma [720p]
Emerging Options for Malignant Pleural Mesothelioma
Author: cancergrace
Added: 04/22/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Mesothelioma surgical trial updates in the UK: MARS2 and MesoTRAP
Exciting clinical trial updates were presented at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland. Speaking from the meeting, Robert Rintoul, PhD, FRCP, of t...
Author: VJOncology
Added: 03/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine
Only one treatment for malignant mesothelioma has been approved since 2003 and rates of the disease are rising worldwide; thus, new treatments must be found. Here, Dean Fennell, PhD, FRCP, of Universi...
Author: VJOncology
Added: 02/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 13, 2018 Category: Cancer & Oncology Source Type: podcasts
Cutting-edge UK trials for mesothelioma: double immuno, arginine depletion and molecular profiling
There is currently an array of exciting clinical trials for mesothelioma, investigating cutting-edge treatments in large patient groups. Here, Dean Fennell, PhD, FRCP, of University Hospitals of Leice...
Author: VJOncology
Added: 02/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 13, 2018 Category: Cancer & Oncology Source Type: podcasts
Mesothelioma biology: key genes and therapeutic targeting
There has been a vast increase in our understanding of the pathology of mesothelioma in the past 5 years, which is hoped to revolutionize the treatment of the disease, whose incidence is rising global...
Author: VJOncology
Added: 02/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 13, 2018 Category: Cancer & Oncology Source Type: podcasts
Mesothelioma: the key unanswered question
Mesothelioma cases are on the rise, in both developed and developing countries. Thus, increased understanding of the underlying mechanisms of the disease is essential. Here, Dean Fennell, PhD, FRCP, o...
Author: VJOncology
Added: 02/13/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 13, 2018 Category: Cancer & Oncology Source Type: podcasts
Mesothelioma Trends in 2018 PrECOG and Ipi Nivo v Chemo
Anne S. Tsao, MD of MD Anderson Cancer Center discusses mesothelioma trends in 2018 with PrECOG and Ipi Nivo v chemo from the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex.co'>http://imedex.co...</a>...
Author: thoraciconcology
Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts
Mesothelioma New Salvage Guidelines Pembrolizumab & Ipilimumab Nivolumab
Anne S. Tsao, MD of MD Anderson Cancer Center discusses the mesothelioma new salvage guidelines pembrolizumab & ipilimumab nivolumab from the 22nd Annual Perspectives in Thoracic Oncology in New York ...
Author: thoraciconcology
Added: 12/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 29, 2017 Category: Cancer & Oncology Source Type: podcasts
